Status: Recruiting
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
The objectives of this study are to evaluate the efficacy and safety of crofelemer treatment in adults affected by Short Bowel Syndrome (SBS) with an ileostomy on parenteral support (PS) in reducing output or PS needs. Crofelemer will be provided as a powder three times daily for 12 weeks and a 4 week follow up. .
Participants needed: 6
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lindsey Russell, MDUpdated: Feb 12, 2026Locations: 1
Eligibility criteria
Patients must understand and provide written informed consent before they can pa... [+12]
Body mass index (BMI) <17.5 or >30 kg/m2; [+26]